Hudson Bay Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,200
Closed -$2.63M 1457
2025
Q2
$2.63M Buy
+17,200
New +$2.64M 0.01% 723
2017
Q2
Sell
-10,300
Closed -$1.28M 658
2017
Q1
$1.28M Sell
10,300
-46,400
-82% -$5.54M 0.02% 574
2016
Q4
$6.53M Buy
56,700
+21,700
+62% +$2.51M 0.14% 146
2016
Q3
$4.13M Buy
+35,000
New +$4.25M 0.1% 162

Other funds holding JNJ

Hudson Bay Capital Management's JNJ Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Johnson & Johnson (JNJ) stake by 153% in Q1 2026, buying an estimated $23.2M and bringing the position to 164,590 shares worth $40.2M. The position accounts for 0.14% of the portfolio, ranked #126.

Hudson Bay Capital Management first reported a position in JNJ in Q3 2016 and has held it in 21 quarters since. The position peaked at $132M in Q1 2023. 4,627 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Hudson Bay Capital Management held 164,590 shares of Johnson & Johnson worth $40.2M as of Q1 2026.
  • Hudson Bay Capital Management bought 99,590 Johnson & Johnson shares in Q1 2026, an estimated $23.2M.
  • Johnson & Johnson made up 0.14% of Hudson Bay Capital Management's portfolio in Q1 2026, its #126 holding.
  • Hudson Bay Capital Management first reported a position in Johnson & Johnson in Q3 2016 and has held it in 21 quarters since.
  • Hudson Bay Capital Management's Johnson & Johnson position peaked at $132M in Q1 2023.
  • 4,627 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.